InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Maricich Yuri, Directeur Médical. Director active across 2 companies, notably Pear Therapeutics, Inc.. Cumulatively, 5 filings have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €31k. Activity tracked since 14 January 2023. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Yuri Maricich serves as Chief Medical Officer of Pear Therapeutics, Inc. In this role, he is responsible for leading the company's medical and clinical activities. Yuri plays a key role in developing new treatments and guiding strategic medical decisions. His expertise in medicine and research is essential for the success of Pear Therapeutics.